Takeda to execute planned acquisition of Adaptate Biotherapeutics

By The Science Advisory Board staff writers

January 11, 2022 -- Takeda Pharmaceutical announced it is exercising its option to acquire Adaptate Biotherapeutics. Takeda will obtain Adaptate's antibody-based variable delta 1 gamma delta T-cell engager platform, as well as its preclinical candidate and discovery pipeline programs.

The planned acquisition complements Takeda's ongoing efforts to research and develop cell engagers for solid tumor applications, bolstered by the novel T-cell engager Cobra platform, which was acquired from Maverick Therapeutics, Takeda said. The acquisition follows Takeda's recently exercised option to acquire GammaDelta Therapeutics.

Adaptate was formed in 2019 as a spinout company from GammaDelta, with investment from Abingworth and Takeda, in which Takeda received an exclusive right to purchase Adaptate for a prenegotiated upfront payment. The acquisitions of Adaptate and GammaDelta are expected to be finalized in the first quarter of Takeda's fiscal year 2022, pending review under applicable antitrust laws.

Financial details of the acquisition were not disclosed.

Immusoft, Takeda ink metabolic disorder cell therapy deal
Immusoft has signed a research and licensing deal with Takeda Pharmaceutical to develop cell therapies for rare inherited metabolic disorders that have...
Codexis, Takeda expand gene therapy collaboration
Codexis has expanded its strategic collaboration and license agreement with Takeda Pharmaceutical for the research and development of an additional gene...
Takeda files dengue vaccine for regulatory approval in EU
The European Medicines Agency, an agency in the European Union (EU), has accepted Takeda Pharmaceutical's filing packages for its dengue vaccine candidate...

Copyright © 2022 scienceboard.net


Conferences
International Society for Cell and Gene Therapy Annual Meeting
May 4 - June 7
San Francisco, California United States
Interphex 2022 Conference
May 24-26
New York, New York United States
American Society for Mass Spectrometry Annual Conference
June 5-9
Minneapolis, Minnesota United States
American Society for Microbiology Microbe Meeting
June 9-13
District of Columbia United States
HPLC 2022
June 18-23
San Diego, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter